RayOne EMV Mini-monovision - Efficiency and Safety of 3 Grades of Mini-monovision

NCT05417633 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-06-14

No results posted yet for this study

Summary

Aim:To determine the effectiveness and subjective satisfaction of patients with bilateral cataract surgery and implantation of intraocular lens (IOL) RayOne EMV with enhanced optic, using different degrees of mini-monovision (up to 0.74, between 0.75 -1.24 and 1.25-1.75). To compare individual groups between themselves . In particular, we would like to compare the independence of spectacle correction when looking into the distance, at medium distance and at reading distance.

Conditions

Interventions

PROCEDURE

intraocular lens - RayOne EMV (Rayner Surgical GmbH,Berlin, Deutschland)

Inducing different values of monovision

Sponsors & Collaborators

  • Somich, s.r.o.

    lead OTHER

Principal Investigators

  • Eliska Studena, MSc · Somich, s.r.o.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2023-03-21

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417633 on ClinicalTrials.gov